These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3386020)

  • 1. [Fluorescent component found in uremic middle-molecules in the hemofiltrate of a dialysis patient].
    Konobu K; Matsumoto T; Sawanishi K
    Nihon Jinzo Gakkai Shi; 1988 Feb; 30(2):161-7. PubMed ID: 3386020
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hydrophobic uremic middle molecules in hemofiltrate of a dialysis patient].
    Konobu K; Matsumoto T; Sawanishi K
    Nihon Jinzo Gakkai Shi; 1988 Feb; 30(2):151-60. PubMed ID: 3386019
    [No Abstract]   [Full Text] [Related]  

  • 3. Uremic toxins.
    Ringoir S; Schoots A; Vanholder R
    Kidney Int Suppl; 1988 Mar; 24():S4-9. PubMed ID: 3283412
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation of sialylcompounds from hemofiltrate of chronic uremic patients and identification by nuclear magnetic resonance.
    Weisshaar G; Brunner H; Friebolin H; Baumann W; Mann H; Opferkuch HJ; Sieberth HG
    Adv Exp Med Biol; 1987; 223():219-22. PubMed ID: 3447438
    [No Abstract]   [Full Text] [Related]  

  • 5. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
    Le Moel G; Strecker G; Cueille G; Boudet J; Man NK; Galli A; Agneray J
    Artif Organs; 1981; 4 Suppl():17-21. PubMed ID: 7295087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of uremic peaks by high performance liquid chromatography and their behavior].
    Koide K; Toyama J; Inoue N; Koshikawa S; Akizawa T; Takahashi K; Hidaka S; Yamane Y; Nakao M; Uehara Y
    Nihon Jinzo Gakkai Shi; 1986 Aug; 28(8):1101-10. PubMed ID: 3807043
    [No Abstract]   [Full Text] [Related]  

  • 7. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
    Popławski A; Myśliwiec M
    Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
    [No Abstract]   [Full Text] [Related]  

  • 8. Uremic middle molecules exist and are biologically active.
    Bergström J; Fürst P; Zimmerman L
    Clin Nephrol; 1979 May; 11(5):229-38. PubMed ID: 455821
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fluorescent chromatogram profiles of uremic hemodialyzates and cirrhosis urines].
    Konobu K; Yamamoto E; Matsumoto T
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1017-23. PubMed ID: 2263023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A; Myśliwiec M; Soszka J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma middle molecules in asymptomatic and "sick" uremic patients.
    Asaba H; Bergström J; Fürst P; Johnson C; Yahiel V
    Artif Organs; 1981; 4 Suppl():137-42. PubMed ID: 7295080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of unusually composed sialyl-compounds from hemofiltrate.
    Brunner H; Weisshaar G; Friebolin H; Baumann W; Mann H; Sieberth HG; Opferkuch HJ
    Int J Artif Organs; 1989 Dec; 12(12):755-61. PubMed ID: 2613356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 14. Amino acid composition of uremic middle and low molecular weight retention products.
    Bazilinski N; Shaykh M; Ahmed S; Musiala T; Williams RH; Poulos A; Dubin A; Dunea G
    Adv Exp Med Biol; 1987; 223():197-204. PubMed ID: 3447436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fragments from albumin and beta 2-microglobulin--constituents of the middle molecule fraction in hemofiltration].
    Kausler E; Spiteller G
    Biol Chem Hoppe Seyler; 1991 Sep; 372(9):849-55. PubMed ID: 1772598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["The middle molecules" are uremic toxins (author's transl)].
    Hanicki Z; Cichocki T
    Przegl Lek; 1978; 35(2):301-5. PubMed ID: 652997
    [No Abstract]   [Full Text] [Related]  

  • 17. Mass spectrometry in the search for uremic toxins.
    Niwa T
    Mass Spectrom Rev; 1997; 16(6):307-32. PubMed ID: 9703693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Middle molecules as uremic toxins (status of the problem)].
    Gudim VI; Gabriélian NI
    Lab Delo; 1985; (3):145-51. PubMed ID: 2581043
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography].
    Kovalishin IaF; Nikolaev VG; Baran EIa; Dudar' IA; Iushko LA
    Vopr Med Khim; 1988; 34(6):23-6. PubMed ID: 3238937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Uremic toxin and dialysis].
    Kobayashi K; Maeda K; Kawaguchi S
    Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):412-4. PubMed ID: 988343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.